MARKET

QGEN

QGEN

Qiagen
NYSE
44.96
-0.25
-0.55%
Pre Market: 45.22 +0.26 +0.58% 07:58 12/19 EST
OPEN
45.02
PREV CLOSE
45.21
HIGH
45.38
LOW
44.78
VOLUME
1.86K
TURNOVER
0
52 WEEK HIGH
51.88
52 WEEK LOW
37.43
MARKET CAP
9.75B
P/E (TTM)
24.40
1D
5D
1M
3M
1Y
5Y
1D
Qiagen sees synthetic share repurchase completed in January
TipRanks · 20h ago
QIAGEN Shares To Begin Trading On January 8, 2026, Post-Reverse Stock Split On NYSE And Frankfurt Exchange
Benzinga · 20h ago
QIAGEN To Return $500M To Shareholders Through Synthetic Share Repurchase And Reverse Stock Split; Every 20 Issued QIAGEN Shares Will Be Consolidated Into 19 QIAGEN Shares, Leading To A Reduction Of ~10.9M Shares From The Level Of 217.7M Shares
Benzinga · 20h ago
EC Approves Label Expansion of INCY's Lymphoma Drug Minjuvi
NASDAQ · 22h ago
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million
Barchart · 1d ago
Does Qiagen Offer Long Term Value After Recent Precision Medicine Investments?
Simply Wall St · 2d ago
Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN) and Novan (NOVN)
TipRanks · 3d ago
QIAGEN N.V. Receives Notification on Voting Rights from AFM
TipRanks · 3d ago
More
About QGEN
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Webull offers Qiagen NV stock information, including NYSE: QGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QGEN stock methods without spending real money on the virtual paper trading platform.